Evotec SE logo

EVO

HEALTHCARE

Evotec SE

$3.24+0.04 (+1.25%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving EVO Today?

No stock-specific AI insight has been generated for EVO yet. Check back soon — insights are generated from recent news analysis.

52-Week Range

$2.31$4.80

$3.24

Fundamentals

Market Cap$1.2B
P/E Ratio
EPS$-0.64
Dividend Yield
Dividend / Share
ROE-0.1%
Profit Margin-0.1%
Debt / Equity

Trading

Volume139K
Avg Volume (10D)
Shares Outstanding355.2M

EVO News

21 articles

All 21 articles loaded

Price Data

Open$3.18
Previous Close$3.20
Day High$3.20
Day Low$3.11
52 Week High$4.80
52 Week Low$2.31

About Evotec SE

Evotec SE is a prominent global biotechnology firm headquartered in Hamburg, Germany, specializing in end-to-end drug discovery and development solutions for the pharmaceutical and biotech industries. The company employs a synergistic approach, collaborating with both established pharmaceutical giants and cutting-edge academic institutions to accelerate the advancement of a diverse range of therapeutic programs, including small molecules, biologics, and cell therapies. With a strong and growing pipeline of projects, Evotec is strategically positioned to leverage emerging opportunities in the biopharmaceutical landscape, reinforcing its essential role in driving healthcare innovation and improving patient outcomes.

4.6K employees
Listed June 2, 1999
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Company Details

Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK
Composite FIGI
Share Class FIGI